Trial Profile
Prospective study investigating the efficacy of rosuvastatin in treatment of ischemia-reperfusion in patients who have undergone percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 24 Dec 2015 New trial record